MAKO Medical CEO Chad Price faces a $2.1M NC AG Medicaid settlement, FEC campaign finance scrutiny, and reported credential misrepresentation — a documented pattern across three institutional domains.
CEO and Co-Founder, MAKO Medical Laboratories LLC — Raleigh, North Carolina. Price co-founded MAKO Medical in 2014 alongside COO Josh Arant, growing the clinical diagnostics company significantly during the COVID-19 pandemic through state and federal testing contracts. He presents publicly as a Christian entrepreneur, veteran employer, and community leader. The documented adverse record spans Medicaid civil enforcement, federal election law, and reported credential misrepresentation across a six-year period.
Chad Price, CEO and co-founder of MAKO Medical Laboratories LLC (Raleigh, North Carolina), presents a documented multi-vector adverse record that spans civil Medicaid enforcement, federal election campaign finance, and reported credential misrepresentation — accumulated across a six-year period from 2018 to 2024. The pattern distinguishes him from a single-incident enforcement subject and warrants elevated due-diligence scrutiny from counterparties, compliance teams, and institutional stakeholders.
The anchor finding is a $2.1 million civil settlement reached in March 2024 between MAKO Medical Laboratories LLC and the North Carolina Attorney General, resolving allegations that the company billed the Medicaid program for unnecessary and duplicative urine drug tests on the same patient sample at or near the same time over a five-year period. The settlement carries no admission of liability and constitutes no judicial determination of wrongdoing against MAKO Medical or Chad Price personally. A separate 2020 NC AG Medicaid investigation pre-dates the 2024 settlement and is confirmed as a distinct proceeding.
A second, independent adverse vector involves campaign finance conduct. Federal Election Commission Matter Under Review 7605, filed in May 2018, alleges that Price made approximately $17,500 in federal and multi-state campaign contributions in the name of his mentally disabled adult sister across 13 candidates in five states. The FEC deadlocked 3-3 on enforcement action; this deadlock is not a clearance — three commissioners issued a formal Statement of Reasons finding federal law was clearly violated. South Carolina separately imposed a $20,000 fine on Price for illegal campaign contributions. A North Carolina SBI investigation prompted by these allegations remains active.
A third vector — reported, not adjudicated — involves allegations published by the News and Observer (Dan Kane, February 2020) that Price submitted inflated educational qualifications and work experience to the Wake County Board of Commissioners in connection with his trustee appointment to Wake Technical Community College. Price subsequently resigned from the trustee board in February 2020. This allegation is characterised throughout as reported investigative journalism, not a regulatory or judicial finding.
Two name-collision risks require explicit management. James Shuford Price III — a Raleigh man who pleaded guilty to a $60 million federal healthcare fraud scheme — is a definitively separate individual and must not be conflated with the subject of this report. A second Chad Price associated with Kettlebell Kings and Life Grows Green (Austin, Texas) also appears in public records; the identity question between this individual and MAKO Medical's Chad Price has not been resolved from a primary source and must not be consolidated without independent verification. All adverse findings in this report apply exclusively to Chad Price of MAKO Medical Laboratories LLC, Raleigh, North Carolina.
North Carolina, United States
Active — Named party in $2.1M NC AG civil Medicaid settlement (March 2024)North Carolina, United States
Active — No adverse finding specific to MakoRx confirmedClick any entity card to view detailed information.
The defining analytical concern is not a single enforcement action but a documented multi-vector pattern of conduct across three independent institutional domains — Medicaid billing, federal election law, and government credential representation — spanning six years. This pattern, combined with Price's unusually dense positive public brand, constitutes the core Public Image Contradiction finding and warrants ongoing monitoring rather than a static point-in-time risk assessment.
Undisclosed / Unverified Relationships
• Precise ownership percentage split between Chad Price, Josh Arant, and Adam Price in MAKO Medical LLC — INSUFFICIENT PUBLICLY AVAILABLE INFORMATION
• Whether any holding company or intermediate entity sits between the named co-founders and MAKO Medical LLC — not confirmed from NC Secretary of State registry retrieval
• MakoRx precise ownership structure and formation date — INSUFFICIENT PUBLICLY AVAILABLE INFORMATION
• Whether any entity restructuring occurred during or after the 2018–2022 billing period covered by the NC AG settlement
Chad Price is a civil-regulatory enforcement subject. No criminal indictment, arrest, or personal criminal judgment has been identified against him as of this report's compilation date. The $2.1M NC AG settlement was entered by MAKO Medical Laboratories LLC as a corporate entity with no admission of liability and no judicial determination of wrongdoing. CEO accountability for the underlying billing conduct is an analytical inference from his leadership position, not a confirmed legal finding. The FEC MUR 7605 3-3 deadlock is not a clearance — three commissioners issued a formal Statement of Reasons finding federal law was clearly violated — but equally is not a binding enforcement determination. The South Carolina $20,000 fine is the only confirmed personal financial penalty against Chad Price individually. The NC SBI investigation remains active. All characterisations in this report are governed by these distinctions.
NC AG Civil Settlement — MAKO Medical Laboratories LLC | $2.1M Payment | March 28, 2024
VERIFIED PUBLIC — NC AG Press Release, March 28 2024 (ncdoj.gov). Named party: MAKO Medical Laboratories LLC (not Chad Price personally). Allegation: unnecessary and duplicative Medicaid billing for urine drug tests on the same patient sample at or near the same time, January 1, 2018 through December 31, 2022. Settlement amount: $2.1 million paid to North Carolina Medicaid program. Admission of liability: none. Judicial determination of wrongdoing: none. HHS-OIG enforcement tracker cross-references this settlement confirming federal-level visibility. No OIG LEIE exclusion or Corporate Integrity Agreement confirmed from available sources — INSUFFICIENT PUBLICLY AVAILABLE INFORMATION on exclusion status. Source: [VERIFIED PUBLIC] NC AG press release; [VERIFIED PUBLIC] HHS-OIG enforcement index.
South Carolina Campaign Finance Penalty — Chad Price | $20,000 Fine | Date Not Confirmed
VERIFIED PUBLIC (via News and Observer / AOL reporting, Dan Kane, March 28 2024). South Carolina campaign finance authority imposed a $20,000 fine on Chad Price personally for illegal campaign contributions he claimed originated from his businesses. This is the only confirmed personal financial penalty against Chad Price individually identified in this investigation. Precise date and penalty order document not independently retrieved — INSUFFICIENT PUBLICLY AVAILABLE INFORMATION on primary document. Source: [REPORTED — corroborated] AOL/News and Observer (Dan Kane, March 28, 2024).
FEC Matter Under Review 7605 (MUR 7605) — Chad Price / MAKO Medical | Federal Election Commission | Filed May 2018
dismissedVERIFIED PUBLIC — FEC.gov official case record. Respondents: Chad E. Price and MAKO Medical. Allegation: contributions in the name of another person (mentally disabled adult sister) and excessive contributions to a congressional candidate; approximately $17,500 in federal and multi-state contributions alleged across 13 candidates in 5 states. Disposition: 3-3 commissioner deadlock. CRITICAL CHARACTERISATION NOTE: This deadlock is NOT a clearance, NOT a dismissal on the merits, and NOT an acquittal. Three commissioners issued a formal Statement of Reasons (FEC document 7605_21.pdf) finding federal law clearly prohibits contributions in the name of another and that the subject made such a contribution. Three commissioners voted to exercise prosecutorial discretion to dismiss. No majority existed for either outcome. The matter has not been resolved by a binding enforcement determination. Source: [VERIFIED PUBLIC] FEC MUR 7605 case record (fec.gov/data/legal/matter-under-review/7605); [VERIFIED PUBLIC] FEC Statement of Reasons (fec.gov/files/legal/murs/7605/7605_21.pdf).
NC State Bureau of Investigation — Campaign Contribution Investigation | 2020 — Status: Active
pendingVERIFIED PUBLIC (via News and Observer / AOL reporting, Dan Kane). NC SBI investigation was prompted by campaign contribution allegations first reported by Axios and WBTV and subsequently by the News and Observer. Investigation concerns contributions made in the name of Price's mentally disabled sister. Status as of March 2024 reporting: active — no confirmed resolution, charge, or closure. Source: [REPORTED — corroborated] AOL/News and Observer (Dan Kane, March 28, 2024).
Separate 2020 NC AG Medicaid Investigation — MAKO Medical | Outcome Unconfirmed
pendingVERIFIED PUBLIC (via News and Observer / AOL reporting). A separate NC AG Medicaid investigation into MAKO Medical was reported in 2020 — this is confirmed as distinct from the 2024 civil settlement. Following this reporting, AG Josh Stein donated $12,400 in MAKO-related campaign contributions to charity to underscore the integrity of NC DOJ investigations. This divestiture is properly characterised as a conflict-of-interest management action by the AG's office; it does not imply prosecutorial misconduct or quid pro quo. Outcome of the 2020 investigation itself: NOT CONFIRMED as resulting in a separate settlement or penalty — INSUFFICIENT PUBLICLY AVAILABLE INFORMATION. Source: [REPORTED] AOL/News and Observer (Dan Kane, March 28, 2024).
Select an event to view details
Official Regulatory Statements and Documented Subject Conduct
"Three FEC commissioners issued a formal Statement of Reasons finding: 'Federal law clearly prohibits contributions in the name of another person.' The deadlock that followed does not constitute a finding of no violation."
— FEC MUR 7605 — Statement of Reasons, three dissenting commissioners (VERIFIED PUBLIC — fec.gov/files/legal/murs/7605/7605_21.pdf)
"The settlement resolves allegations that between January 1, 2018 and December 31, 2022, MAKO Medical gave health care providers the option to order two urine drug tests for patients conducted on the same sample at or near the same time, with only one being medically necessary under North Carolina Medicaid Policy."
— North Carolina Attorney General Josh Stein — Official Press Release, March 28, 2024 (VERIFIED PUBLIC — ncdoj.gov)
3-3 FEC Deadlock ≠ Clearance
The FEC's 3-3 split on MUR 7605 is not an acquittal, not a dismissal on the merits, and not a finding of no violation. Three commissioners formally concluded the law was clearly violated. This distinction is mandatory for accurate compliance-grade characterisation.
No DMCA takedown activity, legal suppression of news content, or cease-and-desist letters to journalists have been identified from available public sources in connection with Chad Price or MAKO Medical Laboratories. The availability of Dan Kane's News and Observer investigative reporting for citation in the FEC case file supplement suggests no successful suppression of primary reporting occurred. INSUFFICIENT PUBLICLY AVAILABLE INFORMATION on whether any such suppression was attempted but unsuccessful.
MAKO Medical Laboratories — Employee Review Profile Not Independently Verified
MAKO Medical Laboratories operates a significant employer footprint in North Carolina, with the company's veteran-hiring and community employer brand prominently featured in the subject's public PR narrative. Employee review platform data has not been independently retrieved or verified for this report. No adverse employment or workplace conduct findings have been identified from available public sources. This field reflects an investigative gap, not a confirmed finding.
Chad Price's public brand is unusually constructed and thematically specific for a private healthcare laboratory CEO. Documented PR pillars include: (1) Christian faith-based entrepreneurship — explicitly cited in trade and lifestyle profiles; (2) veteran-hiring commitment — prominently featured in company marketing and award submissions; (3) Forbes recognition — referenced in public profiles as a legitimacy anchor; (4) community philanthropy — board appointments and civic leadership, including the Wake Tech trustee appointment; (5) COVID-19 healthcare hero narrative — MAKO Medical's testing expansion during the pandemic was used to frame the company as a national healthcare infrastructure asset. The gap between this curated brand and the concurrent adverse record — civil Medicaid billing settlement, FEC-investigated campaign conduct, reported credential inflation submitted to a public body — is the defining editorial finding of this investigation. The brand construction appears to have preceded adverse events in some cases (Forbes coverage) and to have continued through and after adverse events, raising the analytical (INFERRED) question of whether positive PR placement was coordinated to displace adverse coverage. This inference requires further evidentiary support before publication.
The claims analysis confirms three distinct adverse finding categories for Chad Price and MAKO Medical: (1) a verified civil Medicaid billing settlement ($2.1M, corporate entity, no admission), (2) a verified personal campaign finance penalty (SC $20,000 fine) alongside a formally unresolved federal election law matter (FEC 3-3 deadlock — not a clearance) and an active NC SBI investigation, and (3) a reported but unadjudicated credential misrepresentation allegation corroborated by Price's resignation behaviour. No criminal charge against Chad Price personally has been confirmed. The James Shuford Price III identity collision risk is formally quarantined. The Austin TX Chad Price identity question remains unresolved pending primary-source verification.
Chad Price maintains a documented public-facing brand identity across professional and entrepreneurial media channels. He is profiled on inspirery.com with self-reported content emphasising faith, entrepreneurship, and mission-driven business. MAKO Medical Laboratories has an active corporate web presence promoting its veteran-hiring commitments, healthcare mission, and COVID-19 testing contributions. Forbes coverage is referenced in public profiles as a credibility anchor. The subject's LinkedIn and social media presence have not been independently retrieved for this report — social media profile content is therefore characterised as UNVERIFIED at the individual account level. The Kettlebell Kings and Life Grows Green affiliations (Austin, TX) are NOT consolidated into this digital footprint pending primary-source identity verification — treat as a distinct individual until confirmed otherwise.
MAKO Medical Laboratories LLC operates an active corporate website. Website content has not been archived or retrieved for temporal evolution analysis in this investigation. The company's public-facing narrative prominently features healthcare mission, veteran hiring, and community partnership themes — themes that directly contrast with the concurrent adverse regulatory record covering the same operational period. Whether the website content was modified, expanded, or repositioned in response to the 2020 N&O investigative reporting or the 2024 settlement announcement is an outstanding investigative gap. Archive.org temporal retrieval of the MAKO Medical website is recommended as a follow-up research action. MakoRx's digital footprint has not been independently assessed.
The adverse record involving MAKO Medical Laboratories and Chad Price has been the subject of investigative journalism in North Carolina's largest newspaper, the News and Observer, with reporting under the byline of Dan Kane — a journalist with documented access to regulatory filings, FEC records, and government sources. The reporting has prompted concrete institutional responses: a Wake County Commissioner returned campaign contributions, the NC AG divested $12,400 in related contributions, and Price resigned from a public trustee board. The FEC MUR 7605 complaint was filed by an identified complainant (not anonymous) and generated a formal Statement of Reasons from three commissioners. The $2.1M settlement was announced by the NC AG in an official press release. The community and institutional response to this adverse record is documented and multi-actor, providing corroborating context for the credibility of the underlying reporting.
Chad Price and Josh Arant co-founded MAKO Medical Laboratories in Raleigh, North Carolina; Price assumed the role of CEO.
Start of the NC AG civil settlement's covered period; MAKO Medical allegedly began billing for unnecessary and duplicative urine drug tests under North Carolina Medicaid.
Federal Election Commission complaint filed initiating MUR 7605 against Chad Price and MAKO Medical for alleged contributions in the name of his mentally disabled adult sister (~$17,500 across 13 candidates in 5 states).
Dan Kane (News and Observer) published investigative reporting on Price's campaign contribution conduct and allegations that he submitted inflated educational qualifications and work experience to the Wake County Board of Commissioners (REPORTED — not adjudicated).
Chad Price resigned from the Wake Technical Community College trustee board following News and Observer investigative reporting; Wake County Commissioner returned all Price-linked campaign contributions.
Separate NC AG Medicaid investigation into MAKO Medical reported; AG Josh Stein donated $12,400 in MAKO-related campaign contributions to charity as a conflict-of-interest management action — outcome of 2020 investigation not confirmed as resulting in a separate settlement.
NC State Bureau of Investigation opened an investigation into campaign contribution allegations against Price following initial reporting by Axios, WBTV, and the News and Observer; status reported as active as of March 2024.
South Carolina campaign finance authority imposed a $20,000 personal fine on Chad Price for illegal campaign contributions he claimed originated from his businesses; the only confirmed personal financial penalty against Price individually.
FEC commissioners deadlocked 3-3 on MUR 7605; three commissioners issued a formal Statement of Reasons finding federal law was clearly violated; three voted to dismiss on prosecutorial-discretion grounds — not a clearance or acquittal.
End of the five-year Medicaid billing period (January 2018 – December 2022) covered by the 2024 NC AG civil settlement with MAKO Medical LLC.
NC Attorney General Josh Stein announced a $2.1 million civil settlement with MAKO Medical Laboratories LLC for alleged unnecessary and duplicative Medicaid billing for urine drug tests between January 2018 and December 2022; no admission of liability; no personal civil judgment against Chad Price confirmed.
HHS Office of Inspector General enforcement tracker cross-indexed the MAKO Medical civil settlement, confirming federal-level visibility; no OIG exclusion or Corporate Integrity Agreement confirmed from available sources.
The following areas could not be fully verified and represent limitations of this investigation:
Chad Price, CEO and co-founder of MAKO Medical Laboratories LLC, presents a documented multi-vector adverse record that is analytically significant not because of any single confirmed finding but because of the cross-domain pattern it represents. Three independent institutional domains — civil Medicaid enforcement ($2.1M settlement, five-year billing period, HHS-OIG federal cross-index), federal and state election law (FEC MUR 7605 with formal Statement of Reasons finding by three commissioners, SC $20,000 personal fine, active NC SBI investigation), and reported credential misrepresentation to a public government body (N&O investigative reporting, resignation, institutional responses) — have each generated confirmed or credibly reported adverse findings against the subject or his company within a six-year window. No criminal charges have been filed against Chad Price personally as of this report's compilation date, and the $2.1M Medicaid settlement was entered by MAKO Medical LLC with no admission of liability. These distinctions are material and must be preserved in any downstream use of this analysis.
The investigation has identified six material evidence gaps that limit the completeness of the current analysis: OIG exclusion status, N&O article direct retrieval, NC SBI investigation outcome, 2020 NC AG investigation resolution, Austin TX identity confirmation, and multi-state billing exposure. These gaps represent genuine investigative limitations, not inferential failures. The report's findings are assessed to be reliable at the current evidence tier and jurisdiction. The two identity disambiguation risks — James Shuford Price III (definitively separate individual, absolute quarantine) and the Austin TX Chad Price (unresolved, do not consolidate) — must be managed explicitly in any compliance, due diligence, or screening application of this analysis. The subject's right of reply to the key adverse findings (Medicaid settlement characterisation, FEC matter, credential inflation allegation, Wake Tech resignation) should be sought before any published output is finalised.
This report is produced for informational and due-diligence purposes only. It does not constitute legal advice, a legal finding, or a determination of liability. All allegations are presented as allegations only; settled matters are presented with their full non-admission and non-adjudication context preserved. The $2.1M NC AG civil settlement includes no admission of liability and constitutes no judicial determination of wrongdoing by MAKO Medical Laboratories LLC or Chad Price individually. The FEC MUR 7605 3-3 deadlock is not a clearance, acquittal, or finding of no violation. The credential inflation allegation is sourced from investigative journalism and has not been adjudicated by any court or regulatory body. James Shuford Price III is a definitively separate individual from the subject of this report; his DOJ guilty plea and $60M fraud conviction must not be attributed to Chad Price of MAKO Medical under any circumstances. Readers and downstream users bear independent responsibility for verifying claims before acting on this analysis.
Attorney General Josh Stein Reaches $2.1 Million Medicaid Settlement with MAKO Medical
North Carolina Attorney General Josh Stein· 2024-03-28
NC AG Official Press Release, March 28, 2024
Primary regulatory source. Confirms named party (MAKO Medical LLC), settlement amount ($2.1M), covered period (Jan 2018–Dec 2022), allegation (unnecessary/duplicative UDT billing), non-admission of liability. Most authoritative source for settlement characterisation.
Attorney General Josh Stein Reaches $2.1 Million Medicaid Settlement with MAKO Medical — OIG Enforcement Tracker
HHS Office of Inspector General· 2024-03-28
HHS-OIG Enforcement Tracker, 2024
Federal-level cross-index of the MAKO Medical NC AG civil settlement. Confirms federal visibility and classification as state healthcare fraud enforcement action. No separate federal exclusion or CIA confirmed from this source.
Matter Under Review 7605 — Chad E. Price / MAKO Medical
Federal Election Commission· 2018-05-01
FEC MUR 7605 Official Case Record
Primary regulatory source. Confirms complaint filed May 2018, named respondents (Chad E. Price, MAKO Medical), allegation (contributions in name of another person and excessive contributions), 3-3 deadlock disposition. Not a clearance.
Statement of Reasons — MUR 7605 — Finding That Federal Law Was Clearly Violated
Federal Election Commission — Three Dissenting Commissioners· 2020-01-01
FEC MUR 7605, Document 7605_21.pdf
Three commissioners formally found that federal law clearly prohibits contributions in the name of another person and that the subject made such a contribution. This is a formal legal opinion by three commissioners, not a binding enforcement determination. Critical for accurate characterisation of the FEC deadlock.
FEC MUR 7605 Case Supplement — Referencing N&O February 2020 Investigative Reporting
Federal Election Commission — OGC Case Supplement· 2020-02-01
FEC MUR 7605, Document 7605_09.pdf
Confirms FEC case supplement references N&O February 2020 investigative article on Price's campaign contributions across 13 candidates in 5 states. Confirms the existence and subject matter of the N&O articles via official case file citation.
Raleigh-Based MAKO Medical to Pay $2.1M to Settle Unnecessary Medicaid Billing Claims
AOL / News and Observer (Dan Kane)· 2024-03-28
Dan Kane, News and Observer (syndicated via AOL), March 28, 2024
Primary media source. Named investigative journalist with documented source access. Confirms co-founders, 2020 prior investigation, $12,400 AG divestiture, five contributions in ward's name, SC $20,000 fine, active NC SBI investigation. Corroborates primary regulatory sources.
Investigation: Chad Price's Campaign Contributions and Board Credential Allegations
News and Observer (Dan Kane)· 2020-02-06
Dan Kane, News and Observer, February 6, 2020
Primary investigative article on campaign contribution conduct and credential inflation allegation. Confirmed as existing via FEC case supplement citation. Direct retrieval may require subscription. Credential inflation allegation is REPORTED — not adjudicated. This is the source for the Wake Tech trustee credential allegation.
Wake Commissioner Returns MAKO Medical CEO's Campaign Money
MSN / Regional Press· 2020-02-01
MSN regional press report, February 2020
Confirms Wake County Commissioner returned all Chad Price-linked campaign contributions following N&O investigative reporting. Independently verifiable corroborating fact for the N&O reporting. Does not itself confirm the credential inflation allegation.
Raleigh Man Pleads Guilty to Receiving More Than $60 Million in Fraudulent Claims — James Shuford Price III
DOJ U.S. Attorney's Office, Eastern District of North Carolina· 2023-01-01
DOJ USAO-EDNC Press Release
ABSOLUTE QUARANTINE — DISAMBIGUATION USE ONLY. James Shuford Price III is a DEFINITIVELY SEPARATE INDIVIDUAL from Chad Price of MAKO Medical. This source must never appear in the same paragraph as adverse claims about the subject. Listed here solely to formally document and quarantine the misidentification risk.
James Shuford Price III — Raleigh Man Pleads Guilty to $60M Healthcare Fraud
ABC11· 2023-01-01
ABC11 reporting on James Shuford Price III
ABSOLUTE QUARANTINE — DISAMBIGUATION USE ONLY. James Shuford Price III is a definitively separate individual. This source documents the misidentification risk for compliance screening purposes only and must never be used in adverse attribution about Chad Price of MAKO Medical.
Chad Price — Founder and CEO of MAKO Medical Laboratories Profile
Inspirery.com· 2020-01-01
Inspirery.com subject profile — self-reported content
Used for public brand analysis only. Self-reported content; individual claims not independently verified. Relevant as documentation of the subject's curated public identity narrative for the Public Image Contradiction analytical framework. Identity note: confirms MAKO Medical CEO Chad Price (not Austin TX individual) — but formal primary-source identity verification still required.
High Risk · Tier C. The risk profile associated with Chad Price of MAKO Medical Laboratories is anchored by a confirmed $2.1 million North Carolina civil Medicaid settlement cross-indexed by federal HHS-OIG enforcement trackers, a prior separate state Medicaid investigation generating a documented conflict-of-interest episode involving the Attorney General, and a Federal Election Commission matter involving alleged contributions in another person's name that resulted in a formal dissenting Statement of Reasons from three commissioners finding the law was clearly violated. Secondary risk vectors include reported credential misrepresentation to a government body resulting in a public resignation, derivative compliance exposure through subsidiary MakoRx, and two material identity-conflation risks — most critically the risk of misattributing a federal healthcare fraud guilty plea (James Shuford Price III) to the subject — which require prominent documentation in any compliance output. No personal criminal charges against Chad Price have been confirmed, and all adverse regulatory findings against MAKO Medical LLC were settled without judicial determination or admission of liability.
* This report is maintained as a living investigative record. Evidence is categorized by verification status and source type. User submissions are reviewed before inclusion.
Regional Editor for Central Asia, based in Almaty. Investigates resource industries, state-linked enterprises, and cross-border commercial networks.
This report is maintained as a living investigative record. Evidence is categorized by verification status and source type. User submissions are reviewed before inclusion.
Subjects, representatives, and counsel may submit additional or amended responses at any time. The channel remains open — every submission is reviewed manually before publication.
A restricted research workspace from Investigations.org — daily lead intake from twelve monitored source categories, scored and source-linked for human review.


GTV Media Group settled SEC charges for $539M after raising $452M in unregistered offerings. Founder convicted, sentenced 30 years. Investor fraud examined.
Former Binance UK head and Eqonex CEO named in dismissed SDNY securities class action. FCA raised beneficial-ownership concerns during his dual executive tenure.
Gstaad Brokers Ltd, offshore arm of FXVC/Finteractive, faces FCA enforcement, CySEC fines, licence revocation & alleged EU solicitation via Seychelles shell.
FCA-regulated eMerchantPay's auditor resigned citing governance failures. Reynisson faces alleged cybercrime links, Panama Papers listing, and regulatory blind spots.
SEC alleges Jonathan Adam ran a $61.5M crypto Ponzi scheme via GCZ Global LLC while concealing three prior felony convictions. Asset freeze imposed. Case expanding.
27 former employees allege Lubin stripped ConsenSys AG equity in a Swiss-to-Delaware restructuring. JPMorgan named co-defendant. SEC case closed, NY suit active.
A due-diligence map of the OFAC-designated Alex Saab network: Group Grand Limited across Hong Kong, Mexico and Dubai, the Saab brothers, and shells in Panama, Turkey and Colombia.
How Pennsylvania's Accelerated Rehabilitative Disposition clears a criminal charge without a conviction, and the limits that keep records visible to law enforcement and PennDOT, grounded in the Carla Risoldi diversion.
Carla Risoldi was charged in the 2015 Clairemont insurance-fraud case, then routed into diversion with no conviction. What the public record shows for due diligence.
Structured intelligence intake, watchlist tracking, custom alerts, and mobile access — and the means to underwrite the archive's independence.
Get Involved
We moderate comments to keep this a respectful and safe place. We have a zero-tolerance approach to user-to-user personal abuse. Please follow the house rules.
Participate in discussion, add context, and respond to this report.
* This discussion is moderated. Keep comments factual, relevant, and constructive. All submissions are reviewed before publication.
Submit verified tips, supporting evidence, or additional intelligence.
Request factual corrections or submit verifiable updates for this report.
* This discussion is moderated. Keep comments factual, relevant, and constructive. All submissions are reviewed before publication.
No comments yet. Be the first to comment!